Press release
Hormonal Infertility Market Report 2025: Market Trends, Industry Insights, and Future Growth Outlook
Hormonal Infertility Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/hormonal-infertility-market?kb
Latest M&A Activity
M&A activity in the fertility space has been subdued in the US during 2025, with only a few deals. Significant transactions include Abu DhabiPureHealth's $2.3 billion acquisition of Hellenic Healthcare Group (which performs IVF cycles) and IVI RMA Global's $400-450 million acquisition of ART Fertility Clinics chain.​
Other deals involved strategic affiliations and smaller acquisitions such as NewGen IVF's purchase of MicroSort, a sex selection technology company, and clinic consolidations by HRC Fertility.​
The fertility market is expected to pick up deal activity in late 2025 and 2026 due to growing demand for advanced hormonal and IVF therapies
Abu DhabiPureHealth acquisition of Hellenic Healthcare Group for $2.3 billion, expanding fertility and IVF service reach across Europe and the Gulf region. Hellenic Healthcare Group performs approximately 15,000 IVF cycles annually.​
IVI RMA Global acquired a 55% stake in ART Fertility Clinics for around $400-$450 million, adding multiple IVF centers in Latin America, consolidating its global fertility footprint.​
Other smaller but strategic deals include NewGen IVF acquiring MicroSort, a sex selection technology company, and HRC Fertility purchasing regional fertility clinics to expand decentralized offerings
Key Players:
Par Pharmaceutical, TerSera Therapeutics LLC, Merck & Co. Inc, Teva Pharmaceuticals, AbbVie Inc, Sanofi S.A, Incepta Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd
New Product Launches and Innovations
AI-powered embryo selection, advanced cryopreservation (vitrification), non-invasive genetic screening, and personalized genomic approaches are transforming IVF success and hormonal infertility treatment outcomes.​
Combination hormonal therapies like Pergoveris® (r-hFSH + r-hLH) use pre-filled pens to simplify ovarian stimulation, improve patient ease, and reduce costs. Pergoveris is licensed in 74 countries and under FDA review for the US market in 2025.​
Stem cell therapies and novel hormonal modulators are increasingly explored to address complex infertility causes.
Growth Forecast Projected:
The Global Hormonal infertility Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Hormonal infertility Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=hormonal-infertility-market?kb
Key Segments:
By Drug Class: (Direct thrombin inhibitors, Direct factor Xa inhibitors, Others)
By Indication: (Atrial fibrillation (AF), Nonvalvular atrial fibrillation (AF), Deep vein thrombosis, Others)
By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
By Treatment: (Medications, Surgery, Assisted Reproductive Technology, Others)
By Diseases: (POS, Pituitary Tumors, Diabetes, Menopause, Cushing's Syndrome, STDs, Polyps & Fibroids, Others)
By Treatment Sales: (End-User, Distribution Channel, Others)
Latest FDA Approvals in 2025
FDA approvals include several novel hormonal agents and supportive fertility drugs fast-tracked under priority review vouchers. Notables include:
Pergoveris (expected FDA submission in 2025) for medically assisted reproductive cycles.
Other FDA novel drug approvals expanding women's health include Gepotidacin (a new antibiotic), Suzetrigine (pain), and Pembrolizumab Qlex (cancer), indicating the broader regulatory momentum.​
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hormonal-infertility-market?kb
FAQ's
Q: How fast is the Hormonal infertility Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 10.05% from 2025 to 2032
2025 YTD sees substantial M&A activity with mega deals like Abu DhabiPureHealth-Hellenic Healthcare and IVI ART Fertility Clinics driving global consolidation. FDA anticipation peeks around Pergoveris as a combination hormone therapy for IVF. Emerging product innovation emphasizes AI-driven personalized protocols, smart drug delivery systems, and novel biologics to improve infertility treatment success and patient experience.
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/hormonal-infertility-market?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hormonal Infertility Market Report 2025: Market Trends, Industry Insights, and Future Growth Outlook here
News-ID: 4236295 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Matcha Market to Grow at 10.02% CAGR, Reaching USD 7,835.5 million …
The global Matcha Market reached USD 3,650.0 million in 2024 and is projected to reach USD 7,835.5 million by 2032, growing at a CAGR of 10.02% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Starbucks introduced a new line of premium ceremonial-grade matcha beverages across all US locations.
✅ In October 2025, The FDA approved matcha's health claims regarding antioxidant properties…
Assisted Reproductive Technology Market 2025: Industry Developments, Future Grow …
Assisted Reproductive Technology Market reached US$ 26.32 billion in 2024 and is expected to reach US$ 46.21 billion by 2033, growing at a CAGR of 6.8 % during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Assisted Reproductive Technology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and…
United States Sheet Metal Fabrication Market Insights: Industry Developments and …
DataM Intelligence has published a new research report on "Sheet Metal Fabrication Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This…
Vertebroplasty and Kyphoplasty Market 2025: Industry Developments, Future Growth …
Vertebroplasty and Kyphoplasty Market reached US$ 1.2 billion in 2023 and is expected to reach US$ 1.7 billion by 2031, growing at a CAGR of 5% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Vertebroplasty and Kyphoplasty Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.…
More Releases for IVF
IVF Services Market Set for Explosive Growth | Nova IVF, Boston IVF, Monash IVF
HTF MI recently introduced Global IVF Services Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Some key players from the complete study are Virtus Health, Monash IVF, Care Fertility, Apollo Hospitals, Boston IVF, CooperSurgical, Genea Biomedx,…
IVF Services Market Moving in the Right Direction: Bangkok IVF center, Fertility …
According to HTF Market Intelligence, the Global IVF Services market to witness a CAGR of 0.098% during the forecast period (2023-2029). The Latest Released IVF Services Market Research assesses the future growth potential of the IVF Services market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
IVF Devices and Consumables Market Size To Reach USD 7.73 Billion, Globally, By …
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in awareness toward IVF, growth in demand for advanced IVF technologies, and surge in IVF success…
IVF Services Market size is Generating Revenue of $25.6 Billion by 2026 | Fresh …
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems and single mothers & the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and upsurge in disposable income…
Growth Dynamics on In Vitro Fertilization Market 2020-2026| Key Players: Monash …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined…
How In Vitro Fertilization Market Will Dominate In Coming Years? Key Players: Mo …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined…
